Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125969135 | 12596913 | 5 | F | 20160225 | 20160910 | 20160727 | 20160923 | EXP | PHHY2016DK101396 | NOVARTIS | 0.00 | E | F | Y | 0.00000 | 20160923 | PH | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125969135 | 12596913 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Unknown | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 125969135 | 12596913 | 2 | SS | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Unknown | 2 DF, QHS | Y | 0 | 2 | DF | POWDER | ||||||
| 125969135 | 12596913 | 3 | C | UNIKALK BASIC | 2 | Unknown | 400 MG, BID | U | 0 | 400 | MG | BID | |||||||
| 125969135 | 12596913 | 4 | C | APROVEL | IRBESARTAN | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 125969135 | 12596913 | 5 | C | CLORIOCARD | 2 | Unknown | 75 MG, QD | U | 0 | 75 | MG | QD | |||||||
| 125969135 | 12596913 | 6 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 125969135 | 12596913 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | EVERY MORNING | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125969135 | 12596913 | 1 | Osteoporosis |
| 125969135 | 12596913 | 2 | Constipation |
| 125969135 | 12596913 | 3 | Product used for unknown indication |
| 125969135 | 12596913 | 4 | Hypertension |
| 125969135 | 12596913 | 5 | Coagulopathy |
| 125969135 | 12596913 | 6 | Product used for unknown indication |
| 125969135 | 12596913 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125969135 | 12596913 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125969135 | 12596913 | Arthralgia | |
| 125969135 | 12596913 | Burning sensation | |
| 125969135 | 12596913 | Corneal oedema | |
| 125969135 | 12596913 | Drug effect incomplete | |
| 125969135 | 12596913 | Headache | |
| 125969135 | 12596913 | Mucosal dryness | |
| 125969135 | 12596913 | Mucosal haemorrhage | |
| 125969135 | 12596913 | Muscle spasms | |
| 125969135 | 12596913 | Musculoskeletal pain | |
| 125969135 | 12596913 | Oedema | |
| 125969135 | 12596913 | Pain | |
| 125969135 | 12596913 | Pain in extremity | |
| 125969135 | 12596913 | Paraesthesia | |
| 125969135 | 12596913 | Poor quality sleep | |
| 125969135 | 12596913 | Restless legs syndrome | |
| 125969135 | 12596913 | Seizure | |
| 125969135 | 12596913 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125969135 | 12596913 | 1 | 20160107 | 0 | ||
| 125969135 | 12596913 | 2 | 201503 | 0 |